Группа проектов "Завод лечебного питания, г. Зеленоград"
Название
Завод лечебного питания, г. Зеленоград
Описание
ООО «Скопинский Фармацевтический Завод» планирует реализовать проект по созданию фармацевтического производства лечебного питания. Соответствующее соглашение подписано в рамках ПМЭФ-2025.
Инвестиции
1,5 млрд руб.
Местоположение
Проекты
Активные —
·············· ······ руб, 1 проект
- ID ················ ················ ······ ········ ················ ·············· (························) (···················· ················ ····················) — ········· млрд руб
Отрасли проектов
Регионы проектов
Холдинги
············ ···· ······ ·············· ············ ·········· (·········· ············ ············ ············ ········) —
·············· ············ руб, 1 проект
Топ-11 групп проектов в отрасли
«Лекарственные препараты»
(по активным проектам)
«Лекарственные препараты»
(по активным проектам)
1.
············ ············ ················ ········ ············ —
·········· ············ руб, 2 проекта
2.
·············· ············ ·············· ············ ·········· —
············ ·············· руб, 1 проект
4.
·········· ············ ················ ············ ·············· —
···· ············ руб, 1 проект
7.
················ ·············· ················ ······ ················ —
········ ·········· руб, 1 проект
11.
·············· ············ ············ ············ ················ ······ —
················ ········ руб, 1 проект
Анализ отрасли
Топ-1 групп проектов в отрасли
«Лекарственные препараты»
(по завершенным проектам)
«Лекарственные препараты»
(по завершенным проектам)
1.
······ ·············· ·············· ············ ·········· ················ —
·········· ················ руб, 2 проекта
Анализ отрасли Проекты (1)
········ ·········· ······ ·············· ··········
ИНН:
····················
Адрес:
········ ·············· ···· ·············· ···· ········ ············
Телефон:
+·· (······) ······-····-····, +·· (······) ······-····-····
Сайт:
······································.······
